When you’re diagnosed with non-Hodgkin’s lymphoma (NHL), the next step is to find out the stage of yourcancer. That tells you how muchlymphomais in your body, where it is, and if it has spread outside your lymph system, the network that carries immune cells throughout your body. ...
The prognosis of the non-Hodgkin's lymphomas is determined by In the following paper the Ann Arbor Classification, which was originally conceived of fo
Non-Hodgkin's Lymphoma in the Elderly: A Guide to Drug Treatment. Adverse events are common in the elderly when they undergo potent chemotherapy and the reasons for this are various. Therefore, chemotherapy for elderly pa... Niitsu,N. - 《Drugs & Aging》 被引量: 6发表: 1999年 Malignant...
Cancer of lymph tissue is referred as Non-Hodgkin lymphoma. Lymph tissues are generally found in lymph nodes, spleen and other organs that are part of our immune system. In the case of non-Hodgkin lymphoma, the cancer starts in lymphocytes. The cancer of lymph nodes is named after Dr. Tho...
In an attempt to improve response and survival rates in patients with non-Hodgkin's lymphoma, a relatively intense six drug regimen MATCOP was developed comprising four-weekly cycles of methotrexate (100mg/m2, IVY day 8), Adriamycin (30mg/m2, IVY days 1,2), teniposide (75 mg/rn2, IV...
Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. PURPOSE: To study the clinical features and outcome for primary non-Hodgkin's lymphomas of the nose/nasopharynx (NNP-NHLs) according to immunophenotype. PA....
Burkitt lymphomais a form of non-Hodgkin's lymphomain whichcancerstarts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impairedimmunityand is rapidly fatal if left untreated. However, intensivechemotherapycan achieve long-term survival in...
Novel strategies for the identification of biomarkers of non-Hodgkin lymphoma: evidence from the European Prospective Investigation into Cancer (EPIC)Non-Hodgkin's Lymphomas (NHL) represent the eighth most common cancer in Western Europe. ... R Kelly 被引量: 4发表: 2014年 The incidence of B ce...
Stomach-conserving therapy in primary gastric non-Hodgkin's lymphoma (mucosa-associated lymphoid tissue [MALT]-NHL) is increasingly gaining importance as an alternative to surgery. As a consequence, surgical pathologists have to define histological criteria in pretreatment endoscopic biopsy specimen samples...
In order to evaluate the clinical significance of soluble interleukin-2 receptor (sIL-2R) levels in the serum of patients with Hodgkin's disease (HD), we tested the pretreatment sera of 82 patients. The HD patients had significantly higher sIL-2R levels than normal controls (4787 U/ml vers...